A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Poland- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Ul. Polnocna 24/U1, 20-064 Lublin, Poland
Clinirem Sp. z o.o. in Lublin, Poland specialises in clinical trials of conditions such as Chronic inflammatory demyelinating polyradiculoneuropathy, Myasthenia gravis, Migraine, Primary progressive multiple sclerosis, and other specialisations. This site conducts important research.
At Clinirem Sp. z o.o. in Lublin, clinical research in nervous system diseases focuses on episodic migraine. The studies are designed to evaluate whether a new treatment can help reduce migraine burden and improve symptom control for people living with frequent attacks.
This research supports better options for preventing migraines and improving everyday functioning for patients affected by recurrent headache disorders.
The site is also conducting work in immune system diseases, with a strong emphasis on generalized myasthenia gravis. These trials aim to understand whether a new therapy can be safe and effective for people with this chronic autoimmune condition that affects muscle strength.
Through this work, Clinirem Sp. z o.o. contributes to advancing treatment choices for patients living with complex immune-related disorders.
Clinical trials currently enrolling participants at this site.
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.